Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
18 studies found for:    Angelman Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Angelman Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Minocycline in the Treatment of Angelman Syndrome
Condition: Angelman Syndrome
Intervention: Drug: minocycline
2 Active, not recruiting Characterization of Angelman Syndrome
Condition: Angelman Syndrome
Intervention:
3 Completed
Has Results
Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
Condition: Angelman Syndrome
Intervention: Drug: Levodopa/Carbidopa (4:1)
4 Completed
Has Results
A Trial of Levodopa in Angelman Syndrome
Condition: Angelman Syndrome
Interventions: Drug: Levodopa;   Drug: Placebo Oral Capsule
5 Completed Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome
Condition: Angelman Syndrome
Interventions: Drug: MINOCYCLINE;   Drug: PLACEBO (for Minocycline)
6 Recruiting A Study in Adults With Angelman Syndrome
Condition: Angelman Syndrome
Interventions: Drug: OV101 Regimen 1;   Drug: OV101 regimen 2;   Other: Placebo
7 Completed
Has Results
Dietary Supplements for the Treatment of Angelman Syndrome
Conditions: Angelman Syndrome;   Nervous System Diseases
Interventions: Drug: Betaine;   Drug: Creatine;   Drug: Metafolin;   Drug: Vitamin B12
8 Completed Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Conditions: Rett Syndrome;   Prader-Willi Syndrome;   Angelman Syndrome;   Sleep Problems
Intervention:
9 Recruiting Single Dose Pharmacokinetic (PK) Study
Conditions: Angelman Syndrome;   Fragile X Syndrome
Intervention: Drug: OV101
10 Completed Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances
Condition: Sleep Problems
Interventions: Drug: Circadin 2 mg;   Drug: Circadin 10 mg
11 Completed Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
Conditions: Williams Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   Shprintzen Syndrome;   Smith-Magenis Syndrome;   DiGeorge Syndrome;   Chromosome Abnormalities
Intervention:
12 Completed Genomic Imprinting and Assisted Reproductive Technologies
Conditions: Natural Pregnancy;   Pregnancy, Ovarian
Intervention:
13 Completed Effects of Creatine Supplementation in Rett Syndrome
Condition: Rett Syndrome
Interventions: Dietary Supplement: Creatine monohydrate;   Dietary Supplement: Placebo
14 Recruiting SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
Conditions: 22q11 Deletion Syndrome;   DiGeorge Syndrome;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Monosomy X;   Sex Chromosome Abnormalities;   Cri-du-Chat Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   1p36 Deletion Syndrome
Intervention:
15 Withdrawn An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
Condition: Autism Spectrum Disorder
Intervention: Drug: EPI-743
16 Active, not recruiting Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
Condition: Sleep Disorders
Interventions: Drug: Circadin 2/5/10 mg;   Drug: Placebo
17 Recruiting Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
Conditions: Microdeletion Syndromes;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Sex Chromosome Abnormalities
Intervention:
18 Recruiting Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
Conditions: Trisomy 21;   Trisomy 18;   Trisomy 13;   Sex Chromosome Abnormalities;   Microdeletion Syndromes
Intervention:

Study has passed its completion date and status has not been verified in more than two years.